Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the implications of Dr. Vinay Prasad’s recent appointment as Director of the FDA’s Center for Biologics Evaluation and Research (CBER)

Ticker(s): PFE, JNJ, LLY

Who's the expert?

Institution: Molecupath Consultants, LLC

Sales and business development executive leader with over 15 years of experience accelerating precision medicine commercialization

Interview Goal

to discuss the potential ramifications on cancer trials and standards for accelerated approvals following the appointment of Dr. Vinay Prasad at the Center for Biologics Evaluation and Research.

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.